a fourth generation activating chimeric receptor (ACR) natural killer (NK) cell therapy engineered with an NKG2D ACR, OX40 costimulatory domain, CD3zeta signaling moiety, and membrane bound IL-15 (mb-IL15)
a fourth generation activating chimeric receptor (acr) natural killer (nk) cell therapy engineered with an nkg2d acr, ox40 costimulatory domain, cd3zeta signaling moiety, and membrane bound il-15 (mb-il15)